Paper17548594
Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity.
Da Silva DM and 3 others. J Immunol, 2007. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity. Papers, record 17548594. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17548594
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dendritic Cells | Major topic |
| Human papillomavirus 16 | Major topic |
| Oncogene Proteins, Viral | Major topic |
| Receptors, IgG | Major topic |
| T-Lymphocytes | Major topic |
| Virion | Major topic |
| Animals | |
| Antigen Presentation | |
| Histocompatibility Antigens Class II | |
| Humans | |
| Immunity, Cellular | |
| Mice | |
| Mice, Knockout | |
| Mice, Mutant Strains | |
| Papillomavirus E7 Proteins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA 97296 | NCI NIH HHS | United States | P01CA097296 | PubMed and NIH | NIH RePORTER |
| R01 CA 74397 | NCI NIH HHS | United States | R01CA074397 | PubMed and NIH | NIH RePORTER |
| T32 CA 09659 | NCI NIH HHS | United States | T32CA009659 | PubMed and NIH | NIH RePORTER |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41949652 | Response of dendritic cells and T cells to virus-like particles formed from norovirus viral protein-1 (VP1N) or chimeric molecules containing a fragment of VP1N and polypeptides of echovirus 30. | Med Microbiol Immunol | 2026 | https://conductscience.org/library/papers/41949652 | PubMed |
| 40887107 | HPV-positive HNSCC and Fc-silent PD-1 blockade: a clinical discrepancy that raises next immunological questions. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40887107 | PubMed |
| 39066435 | Macropinocytosis Is the Principal Uptake Mechanism of Antigen-Presenting Cells for Allergen-Specific Virus-like Nanoparticles. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39066435 | PubMed |
| 37170231 | Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice. | Immun Ageing | 2023 | https://conductscience.org/library/papers/37170231 | PubMed |
| 35746552 | Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35746552 | PubMed |
| 35632541 | Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35632541 | PubMed |
| 33853825 | Virus-Like Particle-Drug Conjugates Induce Protective, Long-lasting Adaptive Antitumor Immunity in the Absence of Specifically Targeted Tumor Antigens. | Cancer Immunol Res | 2021 | https://conductscience.org/library/papers/33853825 | PubMed |
| 32582186 | Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs. | Front Immunol | 2020 | https://conductscience.org/library/papers/32582186 | PubMed |
| 31799700 | All the small things: How virus-like particles and liposomes modulate allergic immune responses. | Eur J Immunol | 2020 | https://conductscience.org/library/papers/31799700 | PubMed |
| 31163034 | Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles. | PLoS One | 2019 | https://conductscience.org/library/papers/31163034 | PubMed |
| 30906919 | From prevention to cure, repurposing anti-viral vaccines for cancer immunotherapy. | Biotarget | 2018 | https://conductscience.org/library/papers/30906919 | PubMed |
| 28734174 | Old and new adjuvants. | Curr Opin Immunol | 2017 | https://conductscience.org/library/papers/28734174 | PubMed |
| 27909648 | Fcγ Receptors in Solid Organ Transplantation. | Curr Transplant Rep | 2016 | https://conductscience.org/library/papers/27909648 | PubMed |
| 27274998 | Adjuvants: Classification, Modus Operandi, and Licensing. | J Immunol Res | 2016 | https://conductscience.org/library/papers/27274998 | PubMed |
| 27182559 | T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation. | Papillomavirus Res | 2016 | https://conductscience.org/library/papers/27182559 | PubMed |
| 26509554 | Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems. | Biopolymers | 2016 | https://conductscience.org/library/papers/26509554 | PubMed |
| 26360252 | Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C. | Clin Immunol | 2015 | https://conductscience.org/library/papers/26360252 | PubMed |
| 26059395 | Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions. | Immunology | 2015 | https://conductscience.org/library/papers/26059395 | PubMed |
| 25360749 | Enterovirus-71 virus-like particles induce the activation and maturation of human monocyte-derived dendritic cells through TLR4 signaling. | PLoS One | 2014 | https://conductscience.org/library/papers/25360749 | PubMed |
| 25221553 | The Role of FcRn in Antigen Presentation. | Front Immunol | 2014 | https://conductscience.org/library/papers/25221553 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FCGR3A | 2214 | PubTator's text mining | https://conductscience.org/library/genes/2214 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17548594
GET https://conductscience.org/api/papers/v1/17548594/cited_by?page=2